AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Marksans Pharma Ltd. M&A Activity 2022

Jun 10, 2022

62142_rns_2022-06-10_480a3b79-072b-4360-8b03-bd8ceb4e6eb7.pdf

M&A Activity

Open in viewer

Opens in your device viewer

==> picture [203 x 60] intentionally omitted <==

----- Start of picture text ----- ·t·Marksans Pharma Ltd.----- End of picture text -----

To, National Stock Exchange of India Limited

Exchange Plaza BandraKuria Complex Bandra (E), Mumbai - 400051 Scrip Code: MARKSANS

To, BSE Limited

P. J. Towers Dalal Street Mumbai - 400 001 Scrip Code: 524404

Sub: Intimation under Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Acquisition of Access Healthcare for Medical Products L.L.C.

Further to our letter dated 25[th] April, 2022, kindly be informed that th'e Company has completed the process of acquiring 100% share capital of Access Healthcare for Medical Products LLC based in Dubai, UAE.

Harshavardhan Panigrahi Company Secretary

www.marksanspharma.com